|
|
|
|
|
Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013–2014 |
2562 |
# |
|
|
|
|
|
INPATIENT PREVALENCE, EXPENDITURES AND COMORBIDITIES OF TAKAYASU'S ARTERITIS: A PROPENSITY-MATCHED COHORT STUDY |
2562 |
# |
|
|
|
|
|
Inpatient prevalence, burden and comorbidity of Takayasu's arteritis: Nationwide inpatient sample 2013–2014 |
2561 |
# |
|
|
|
|
|
Inpatient Burden and Resource Utilization of Polymyositis and Dermatomyositis: A 10-year Study of National Inpatient Sample. |
2563 |
# |
|
|
|
|
|
Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year study of national inpatient sample [Hospitalisations et utilisation des ressources dans la polymyosite et la dermatomyosite : étude d'un échantillon national américain de patients hospitalisés sur 10 ans] |
2564 |
# |
|
|
|
|
|
Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014 |
2563 |
# |
|
|
|
|
|
INPATIENT BURDEN AND COMORBIDITIES OF SARCOIDOSIS: NATIONWIDE INPATIENT SAMPLE 2013-2014 |
2562 |
# |
|
|
|
|
|
Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014 |
2563 |
# |
|
|
|
|
|
Injuries due to foreign body aspirations in Georgia: A prevention perspective |
2559 |
# |
|
|
|
|
|
Initiation of antiretroviral treatment with dual nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected infants with less advanced disease in a resource-limited setting: a multi-center study in Thailand 1998-2000. |
2548 |
# |
|
|
|
|
|
Initial response of endothelial cells to acute stimulation with a lipid component: Increase cyclooxygenase activity by induction of COX-2 through activation of tyrosine kinase |
2553 |
# |
|
|
|
|
|
Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidrug-resistant bacteria causing hospital-acquired infections. |
2555 |
# |
|
|
|
|
|
Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated beta-catenin to the nucleus |
2555 |
# |
|
|
|
|
|
Inhibition of UVA-mediated Melanogenesis by Ascorbic Acid through Modulation of Antioxidant Defense and Nitric Oxide System |
2554 |
# |
|
|
|
|
|
Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor |
2563 |
# |
|
|
|
|
|
Inhibition of the human complement component C4 by Flavivirus non-structural protein NS1 |
2553 |
# |
|
|
|
|
|
Inhibition of protein kinase C promotes dengue virus replication |
2559 |
# |
|
|
|
|
|
Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-alpha secretion and apoptosis |
2556 |
# |
|
|
|
|
|
Inhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid. |
2560 |
# |
|
|
|
|
|
Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers |
2549 |
# |
|
|
|
|
|
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells |
2561 |
# |
|
|
|
|
|
Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition |
2563 |
# |
|
|
|
|
|
Inhibition of HCV replication by humanized-single domain transbodies to NS4B |
2559 |
# |
|
|
|
|
|
Inhibition of H5N1 highly pathogenic influenza virus by suppressing a specific sialyltransferase |
2553 |
# |
|
|
|
|
|
Inhibition of dengue virus replication in monocyte-derived dendritic cells by vivo-morpholino oligomers |
2561 |
# |
|
|
|
|
|
Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A. |
2558 |
# |
|
|
|
|
|
Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines |
2554 |
# |
|
|
|
|
|
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria |
2565 |
# |
|
|
|
|
|
Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) |
2562 |
# |
|
|
|
|
|
Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Haemolysis in Patients with Paroxysmal Nocturnal Haemoglobinuria |
2562 |
# |